Chargement en cours...
Teriflunomide for the treatment of relapsing–remitting multiple sclerosis: patient preference and adherence
Multiple sclerosis (MS), a chronic demyelinating neuroinflammatory disease of the central nervous system, is the most common neurological disorder leading to disability in young adulthood. In the last 2 decades, numerous treatments for relapsing–remitting MS have been approved with eleven treatment...
Enregistré dans:
| Publié dans: | Patient Prefer Adherence |
|---|---|
| Auteurs principaux: | , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Dove Medical Press
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4332317/ https://ncbi.nlm.nih.gov/pubmed/25709412 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/PPA.S61651 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|